Matthias L Schroeter Selected Research

Matthias L Schroeter Research Topics

Disease

16	Dementia (Dementias) 01/2022 - 01/2010
16	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2011
13	Atrophy 01/2017 - 07/2007
10	Cognitive Dysfunction 01/2021 - 01/2012
9	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2013
8	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 10/2021 - 06/2010
8	Schizophrenia (Dementia Praecox) 01/2016 - 08/2003
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 03/2011
5	Frontotemporal Dementia (Semantic Dementia) 01/2020 - 01/2011
5	Mood Disorders (Mood Disorder) 03/2015 - 12/2008
3	Hypertension (High Blood Pressure) 01/2020 - 04/2016
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2020 - 01/2018
3	Obesity 01/2019 - 01/2018
2	Tauopathies 01/2022 - 11/2021
2	Corticobasal Degeneration 01/2020 - 01/2017
2	Disease Progression 01/2019 - 01/2018
2	Abdominal Obesity 01/2019 - 01/2018
2	Neurobehavioral Manifestations 05/2018 - 08/2015
2	Prodromal Symptoms 05/2018 - 01/2012
2	Primary Progressive Aphasia 01/2018 - 10/2016
2	Heart Arrest (Cardiac Arrest) 12/2017 - 09/2015
2	Major Depressive Disorder (Major Depressive Disorders) 03/2015 - 12/2008
1	Catatonia 10/2021
1	COVID-19 10/2021
1	Confusion (Bewilderment) 10/2021
1	Hallucinations (Hallucination) 10/2021
1	Autoimmune Diseases of the Nervous System 10/2021
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 11/2020
1	Heart Failure 01/2020
1	Inflammation (Inflammations) 01/2019
1	Dystonia (Limb Dystonia) 11/2018
1	Myocardial Infarction 01/2018
1	Stroke (Strokes) 01/2018
1	Dyskinesias (Dyskinesia) 01/2018
1	Overweight 01/2018
1	Ischemia 12/2017
1	Primary Progressive Nonfluent Aphasia (Progressive Nonfluent Aphasia) 10/2016
1	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2015
1	Vascular Diseases (Vascular Disease) 07/2015
1	Sleep Wake Disorders 07/2015
1	Hypersensitivity (Allergy) 07/2015
1	Bipolar Disorder (Manic Depressive Psychosis) 03/2015
1	Thyroiditis 04/2014
1	Hypothyroidism 04/2014
1	Mental Disorders (Mental Disorder) 01/2012
1	Wernicke Aphasia (Receptive Aphasia) 01/2011

Drug/Important Bio-Agent (IBA)

26	Biomarkers (Surrogate Marker)IBA 10/2021 - 12/2007
15	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 07/2007
8	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2015
8	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2008
7	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2013 - 01/2010
4	Levodopa (L Dopa)FDA LinkGeneric 01/2020 - 07/2013
4	Phosphopyruvate Hydratase (Enolase)IBA 09/2015 - 12/2008
3	Indicators and Reagents (Reagents)IBA 01/2021 - 08/2015
3	Apolipoproteins E (ApoE)IBA 01/2020 - 05/2015
3	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2018 - 08/2016
2	Amyloid beta-PeptidesIBA 01/2022 - 08/2015
2	Retinaldehyde (Retinal)IBA 01/2021 - 07/2015
2	C-Reactive ProteinIBA 01/2019 - 12/2007
2	Antipsychotic Agents (Antipsychotics)IBA 05/2009 - 08/2003
1	PrionsIBA 01/2022
1	ponceau 4R (E 124)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 11/2021
1	AntibodiesIBA 10/2021
1	AutoantibodiesIBA 10/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2021
1	IronIBA 10/2020
1	pro-brain natriuretic peptide (1-76)IBA 01/2020
1	CytokinesIBA 01/2019
1	Citalopram FDA LinkGeneric 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Estrogens (Estrogen)FDA Link 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	PlasticsIBA 11/2018
1	Therapeutic UsesIBA 01/2018
1	chitotriosidaseIBA 01/2018
1	DipeptidesIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Cholinergic Agents (Cholinergics)IBA 10/2016
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 08/2016
1	ApolipoproteinsIBA 04/2016
1	Genetic Markers (Genetic Marker)IBA 07/2015
1	SynucleinsIBA 05/2015
1	Pharmaceutical PreparationsIBA 05/2015
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2015
1	ProteomeIBA 06/2014
1	Blood Proteins (Serum Proteins)IBA 10/2013
1	Hydrocortisone (Cortisol)FDA LinkGeneric 05/2012
1	mesoglycanIBA 11/2011
1	Nerve Growth Factors (Neurotrophins)IBA 01/2010

Therapy/Procedure

6	Therapeutics 04/2019 - 11/2011
4	Deep Brain Stimulation 01/2020 - 01/2013
1	Immunotherapy 10/2021
1	Transcranial Magnetic Stimulation 11/2018
1	Electrodes (Electrode) 01/2018
1	Resuscitation 12/2017
1	Aftercare (After-Treatment) 03/2015
1	Duration of Therapy 04/2014